vs
Side-by-side financial comparison of IMAX CORP (IMAX) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $125.2M, roughly 1.7× IMAX CORP). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs 0.5%, a 2.2% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs 27.1%). IMAX CORP produced more free cash flow last quarter ($28.0M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 25.8%).
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
IMAX vs IRTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $125.2M | $208.9M |
| Net Profit | $637.0K | $5.6M |
| Gross Margin | 57.6% | 70.9% |
| Operating Margin | 19.3% | 1.1% |
| Net Margin | 0.5% | 2.7% |
| Revenue YoY | 35.1% | 27.1% |
| Net Profit YoY | -88.0% | 518.5% |
| EPS (diluted) | $0.02 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $125.2M | $208.9M | ||
| Q3 25 | $106.7M | $192.9M | ||
| Q2 25 | $91.7M | $186.7M | ||
| Q1 25 | $86.7M | $158.7M | ||
| Q4 24 | $92.7M | $164.3M | ||
| Q3 24 | $91.5M | $147.5M | ||
| Q2 24 | $89.0M | $148.0M | ||
| Q1 24 | $79.1M | $131.9M |
| Q4 25 | $637.0K | $5.6M | ||
| Q3 25 | $20.7M | $-5.2M | ||
| Q2 25 | $11.3M | $-14.2M | ||
| Q1 25 | $2.3M | $-30.7M | ||
| Q4 24 | $5.3M | $-1.3M | ||
| Q3 24 | $13.9M | $-46.2M | ||
| Q2 24 | $3.6M | $-20.1M | ||
| Q1 24 | $3.3M | $-45.7M |
| Q4 25 | 57.6% | 70.9% | ||
| Q3 25 | 63.1% | 71.1% | ||
| Q2 25 | 58.5% | 71.2% | ||
| Q1 25 | 61.4% | 68.8% | ||
| Q4 24 | 52.2% | 70.0% | ||
| Q3 24 | 55.8% | 68.8% | ||
| Q2 24 | 49.4% | 69.9% | ||
| Q1 24 | 59.3% | 66.3% |
| Q4 25 | 19.3% | 1.1% | ||
| Q3 25 | 27.2% | -4.4% | ||
| Q2 25 | 15.6% | -10.0% | ||
| Q1 25 | 19.3% | -20.5% | ||
| Q4 24 | 10.3% | -2.5% | ||
| Q3 24 | 21.2% | -34.1% | ||
| Q2 24 | 3.2% | -15.5% | ||
| Q1 24 | 15.3% | -28.9% |
| Q4 25 | 0.5% | 2.7% | ||
| Q3 25 | 19.4% | -2.7% | ||
| Q2 25 | 12.3% | -7.6% | ||
| Q1 25 | 2.7% | -19.3% | ||
| Q4 24 | 5.7% | -0.8% | ||
| Q3 24 | 15.2% | -31.3% | ||
| Q2 24 | 4.0% | -13.6% | ||
| Q1 24 | 4.1% | -34.6% |
| Q4 25 | $0.02 | $0.18 | ||
| Q3 25 | $0.37 | $-0.16 | ||
| Q2 25 | $0.20 | $-0.44 | ||
| Q1 25 | $0.04 | $-0.97 | ||
| Q4 24 | $0.09 | $-0.03 | ||
| Q3 24 | $0.26 | $-1.48 | ||
| Q2 24 | $0.07 | $-0.65 | ||
| Q1 24 | $0.06 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $151.2M | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $337.9M | $152.7M |
| Total Assets | $894.0M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $151.2M | $583.8M | ||
| Q3 25 | $143.1M | $565.2M | ||
| Q2 25 | $109.3M | $545.5M | ||
| Q1 25 | $97.1M | $520.6M | ||
| Q4 24 | $100.6M | $535.6M | ||
| Q3 24 | $104.5M | $522.0M | ||
| Q2 24 | $91.6M | $561.5M | ||
| Q1 24 | $81.0M | $569.1M |
| Q4 25 | $337.9M | $152.7M | ||
| Q3 25 | $349.5M | $121.9M | ||
| Q2 25 | $320.4M | $103.7M | ||
| Q1 25 | $299.5M | $86.7M | ||
| Q4 24 | $299.5M | $90.9M | ||
| Q3 24 | $289.4M | $71.8M | ||
| Q2 24 | $267.2M | $99.2M | ||
| Q1 24 | $258.8M | $90.3M |
| Q4 25 | $894.0M | $1.0B | ||
| Q3 25 | $889.6M | $995.2M | ||
| Q2 25 | $868.6M | $964.0M | ||
| Q1 25 | $848.3M | $926.1M | ||
| Q4 24 | $830.4M | $931.4M | ||
| Q3 24 | $847.6M | $909.7M | ||
| Q2 24 | $827.4M | $919.2M | ||
| Q1 24 | $824.1M | $909.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.4M | $26.2M |
| Free Cash FlowOCF − Capex | $28.0M | $14.5M |
| FCF MarginFCF / Revenue | 22.3% | 6.9% |
| Capex IntensityCapex / Revenue | 1.1% | 5.6% |
| Cash ConversionOCF / Net Profit | 46.11× | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | $118.9M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.4M | $26.2M | ||
| Q3 25 | $67.5M | $34.9M | ||
| Q2 25 | $23.2M | $27.7M | ||
| Q1 25 | $7.0M | $-7.9M | ||
| Q4 24 | $11.5M | $19.2M | ||
| Q3 24 | $35.3M | $24.3M | ||
| Q2 24 | $35.0M | $11.8M | ||
| Q1 24 | $-11.0M | $-52.0M |
| Q4 25 | $28.0M | $14.5M | ||
| Q3 25 | $64.8M | $20.1M | ||
| Q2 25 | $20.9M | $17.3M | ||
| Q1 25 | $5.3M | $-17.3M | ||
| Q4 24 | $6.9M | $12.4M | ||
| Q3 24 | $34.2M | $15.5M | ||
| Q2 24 | $33.5M | $3.4M | ||
| Q1 24 | $-12.1M | $-61.8M |
| Q4 25 | 22.3% | 6.9% | ||
| Q3 25 | 60.7% | 10.4% | ||
| Q2 25 | 22.8% | 9.3% | ||
| Q1 25 | 6.1% | -10.9% | ||
| Q4 24 | 7.4% | 7.5% | ||
| Q3 24 | 37.3% | 10.5% | ||
| Q2 24 | 37.6% | 2.3% | ||
| Q1 24 | -15.3% | -46.8% |
| Q4 25 | 1.1% | 5.6% | ||
| Q3 25 | 2.6% | 7.7% | ||
| Q2 25 | 2.6% | 5.6% | ||
| Q1 25 | 1.9% | 5.9% | ||
| Q4 24 | 5.0% | 4.2% | ||
| Q3 24 | 1.2% | 6.0% | ||
| Q2 24 | 1.8% | 5.7% | ||
| Q1 24 | 1.4% | 7.4% |
| Q4 25 | 46.11× | 4.70× | ||
| Q3 25 | 3.27× | — | ||
| Q2 25 | 2.06× | — | ||
| Q1 25 | 2.99× | — | ||
| Q4 24 | 2.16× | — | ||
| Q3 24 | 2.54× | — | ||
| Q2 24 | 9.78× | — | ||
| Q1 24 | -3.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
